TXG
10X Genomics Inc
Price:  
12.15 
USD
Volume:  
1,891,709.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TXG Relative Valuation

-381.8%
Upside

As of 2025-07-19, the Relative Valuation of 10X Genomics Inc (TXG) is (34.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.15 USD, the upside of 10X Genomics Inc based on Relative Valuation is -381.8%.

The range of the Relative Valuation is (33.64) - (33.62) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 26.4x - 28.9x 27.9x
Forward P/E multiples 24.1x - 26.4x 25.8x
Fair Price (33.64) - (33.62) (34.24)
Upside -376.9% - -376.7% -381.8%
12.15 USD
Stock Price
(34.24) USD
Fair Price

TXG Relative Valuation - Historical P/E Data

Date P/E
2025-07-16 -9.70
2025-07-15 -9.58
2025-07-14 -9.78
2025-07-11 -10.04
2025-07-10 -9.90
2025-07-09 -9.49
2025-07-08 -9.61
2025-07-07 -9.35
2025-07-03 -10.20
2025-07-02 -10.20
2025-07-01 -9.46
2025-06-30 -9.08
2025-06-27 -9.20
2025-06-26 -9.17
2025-06-25 -9.14
2025-06-24 -8.54
2025-06-23 -8.46
2025-06-20 -8.48
2025-06-18 -8.52
2025-06-17 -8.28
2025-06-16 -8.63
2025-06-13 -8.17
2025-06-12 -8.30
2025-06-11 -8.45
2025-06-10 -8.35
2025-06-09 -7.91
2025-06-06 -7.39
2025-06-05 -7.14
2025-06-04 -7.32
2025-06-03 -7.14
2025-06-02 -7.41
2025-05-30 -7.47
2025-05-29 -7.32
2025-05-28 -6.95
2025-05-27 -6.74
2025-05-23 -6.41
2025-05-22 -6.70
2025-05-21 -6.52
2025-05-20 -7.12
2025-05-19 -7.00
2025-05-16 -7.36
2025-05-15 -7.21
2025-05-14 -7.15
2025-05-13 -7.57
2025-05-12 -7.44
2025-05-09 -6.88
2025-05-08 -6.77
2025-05-07 -6.52
2025-05-06 -6.35
2025-05-05 -6.75